OssDsign steps up ambition to generate further clinical evidence for its bone replacement products through key recruitment

Uppsala, February 7, 2022. OssDsign AB (publ.) today announces that Melanie Marshall has been recruited to a new position as Vice President Clinical & Medical Affairs. This is an important step in the strategic ambition to accelerate data collection and publication of clinical evidence for the company’s innovative bone replacement products, OssDsign Cranial PSI and OssDsign Catalyst. Melanie Marshall has a wealth of experience from senior positions at global medtech companies, such as Boston Scientific, Apatech/Baxter and Medtronic.The creation of a new senior position with responsibility